Quarterly report pursuant to Section 13 or 15(d)

Net loss Per Share Attributable to Common Stockholders (Tables)

v3.23.1
Net loss Per Share Attributable to Common Stockholders (Tables)
 3 Months Ended
Mar. 31, 2023
Earnings Per Share [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share
The following potentially dilutive shares were excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented, because including them would have been anti-dilutive (on an as-converted basis):
Three Months Ended
March 31,
2023 2022
Convertible preferred stock —  115,287,015 
Contingently redeemable convertible common stock —  2,750,000 
Common stock options 10,172,491  25,691,329 
Restricted stock units 29,413,894  3,224,181 
Convertible preferred stock warrants —  735,763 
Common stock warrants 5,093,905  688,362 
Private and Public Placement Warrants 14,750,000  — 
Earn-Out Shares 13,005,238  — 
Shares subject to repurchase —  16,539 
Total 72,435,528  148,393,189